跳至主要内容
临床试验/NCT04539067
NCT04539067Unknown2 期

Effect of Controlled Ovarian Stimulation With H FSH and HHMg Vs HMG Alone on Oocyte and Embryo Quality in IcsI Patients

Minia University0 个研究点目标入组 70 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
70
主要终点
Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients

研究概览

简要总结

Investigate and compare the efficacy of H FSH plus HMG Vs HMG alone on oocyte and embryo quality in IcsI patients

详细描述

70 patients divided in to 2groups Group A controlled ovarian stimulation with H FSH and HHMg Group B controlled ovarian stimulation with HMG alone Results will be discussed later

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertil women aged from 20_35yr
  • Normal utreus
  • Normal ovaries
  • unexplained infertility
  • no endometriosis

排除标准

  • 1 - poor responders to gonadotropin 2-Prior history of more than 3unsucceful ICSI 3-Any malformation of sexual organs

研究组 & 干预措施

HMG group

Experimental

Induction of ovulation from 2nd day of cycle Follow diameter of follicle When follicle 18:22mm Receive HMG

干预措施: HHMG (Drug)

H FSH plus HHMG

Experimental

Follow up ovulation from the 2nd day to 5th of menstruation cycle When follicle diameter 18mm to 22mm made induction of ovulation

干预措施: HHMG (Drug)

结局指标

主要结局

Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients

时间窗: 9 months

Comparison between the efficacy of controlled ovarian stimulation with H FSH plus HMG Vs HmG alone on oocyte and embryo quality in IcsI patients

次要结局

未报告次要终点

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Bahgat Tarahony

Eygpt Minia

Minia University

相似试验